These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 33104714)
1. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling. Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714 [TBL] [Abstract][Full Text] [Related]
2. Kdm2a/b Lysine Demethylases Regulate Canonical Wnt Signaling by Modulating the Stability of Nuclear β-Catenin. Lu L; Gao Y; Zhang Z; Cao Q; Zhang X; Zou J; Cao Y Dev Cell; 2015 Jun; 33(6):660-74. PubMed ID: 26004508 [TBL] [Abstract][Full Text] [Related]
3. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1. Gao R; Dong R; Du J; Ma P; Wang S; Fan Z Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091 [TBL] [Abstract][Full Text] [Related]
4. A demethylation deficient isoform of the lysine demethylase KDM2A interacts with pericentromeric heterochromatin in an HP1a-dependent manner. Lađinović D; Novotná J; Jakšová S; Raška I; Vacík T Nucleus; 2017 Sep; 8(5):563-572. PubMed ID: 28816576 [TBL] [Abstract][Full Text] [Related]
5. KDM2A/B lysine demethylases and their alternative isoforms in development and disease. Vacík T; Lađinović D; Raška I Nucleus; 2018; 9(1):431-441. PubMed ID: 30059280 [TBL] [Abstract][Full Text] [Related]
6. Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas. De Nicola I; Guerrieri AN; Penzo M; Ceccarelli C; De Leo A; Trerè D; Montanaro L Histol Histopathol; 2020 Oct; 35(10):1181-1187. PubMed ID: 32901907 [TBL] [Abstract][Full Text] [Related]
7. CxxC-ZF domain is needed for KDM2A to demethylate histone in rDNA promoter in response to starvation. Tanaka Y; Umata T; Okamoto K; Obuse C; Tsuneoka M Cell Struct Funct; 2014; 39(1):79-92. PubMed ID: 24553073 [TBL] [Abstract][Full Text] [Related]
8. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing. Kang JY; Kim JY; Kim KB; Park JW; Cho H; Hahm JY; Chae YC; Kim D; Kook H; Rhee S; Ha NC; Seo SB FASEB J; 2018 Oct; 32(10):5737-5750. PubMed ID: 29763382 [TBL] [Abstract][Full Text] [Related]
9. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer. Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617 [TBL] [Abstract][Full Text] [Related]
10. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription. Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056 [TBL] [Abstract][Full Text] [Related]
11. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells. Rizwani W; Schaal C; Kunigal S; Coppola D; Chellappan S PLoS One; 2014; 9(7):e100888. PubMed ID: 25029110 [TBL] [Abstract][Full Text] [Related]
12. Lysine-specific demethylase 2A enhances binding of various nuclear factors to CpG-rich genomic DNAs by action of its CXXC-PHD domain. Iuchi S; Paulo JA Sci Rep; 2019 Apr; 9(1):5496. PubMed ID: 30940825 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells. Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232 [TBL] [Abstract][Full Text] [Related]
14. Identification of Structural Elements of the Lysine Specific Demethylase 2B CxxC Domain Associated with Replicative Senescence Bypass in Primary Mouse Cells. Deiktakis EE; Abrams M; Tsapara A; Stournaras C; Tsatsanis C; Tsichlis PN; Kampranis SC Protein J; 2020 Jun; 39(3):232-239. PubMed ID: 32270414 [TBL] [Abstract][Full Text] [Related]
15. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes. He J; Shen L; Wan M; Taranova O; Wu H; Zhang Y Nat Cell Biol; 2013 Apr; 15(4):373-84. PubMed ID: 23502314 [TBL] [Abstract][Full Text] [Related]
16. Lysine demethylase 2B regulates angiogenesis via Jumonji C dependent suppression of angiogenic transcription factors. Sasaki Y; Higashijima Y; Suehiro JI; Sugasawa T; Oguri-Nakamura E; Fukuhara S; Nagai N; Hirakawa Y; Wada Y; Nangaku M; Kanki Y Biochem Biophys Res Commun; 2022 May; 605():16-23. PubMed ID: 35306360 [TBL] [Abstract][Full Text] [Related]
17. KDM2A integrates DNA and histone modification signals through a CXXC/PHD module and direct interaction with HP1. Borgel J; Tyl M; Schiller K; Pusztai Z; Dooley CM; Deng W; Wooding C; White RJ; Warnecke T; Leonhardt H; Busch-Nentwich EM; Bartke T Nucleic Acids Res; 2017 Feb; 45(3):1114-1129. PubMed ID: 28180290 [TBL] [Abstract][Full Text] [Related]
18. SRF is a nonhistone methylation target of KDM2B and SET7 in the regulation of skeletal muscle differentiation. Kwon DH; Kang JY; Joung H; Kim JY; Jeong A; Min HK; Shin S; Lee YG; Kim YK; Seo SB; Kook H Exp Mol Med; 2021 Feb; 53(2):250-263. PubMed ID: 33564100 [TBL] [Abstract][Full Text] [Related]
19. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
20. [A CxxC domain that binds to unmethylated CpG is required for KDM2A to control rDNA transcription]. Tsuneoka M; Tanaka Y; Okamoto K Yakugaku Zasshi; 2015; 135(1):11-21. PubMed ID: 25743893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]